Results 71 to 80 of about 18,672,321 (342)
Scientific Data, 2018 Immunology researchers are beginning to explore the possibilities of reproducibility, reuse and secondary analyses of immunology data. Open-access datasets are being applied in the validation of the methods used in the original studies, leveraging ...
S. Bhattacharya +12 more
semanticscholar +1 more source
Open to the public: paywalls and the public rationale for open access medical research publishing
Research Involvement and Engagement, 2020 Public voices have largely been absent from the discussions about open access publishing in medical research. Yet the public have a strong interest in ensuring open access of medical research findings because of their roles as funders, advocates ...
S. Day +3 more
semanticscholar +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa +8 more
wiley +1 more source
Evaluating the impact of open access policies on research institutions
eLife, 2020 The proportion of research outputs published in open access journals or made available on other freely-accessible platforms has increased over the past two decades, driven largely by funder mandates, institutional policies, grass-roots advocacy, and ...
C. Huang +6 more
semanticscholar +1 more source
Open access in South Africa: A case study and reflections
, 2014 In this paper, we locate open access in the South African higher education research context where it is, distinctively, not shaped by the policy frameworks that are profoundly changing research dissemination behaviour in other parts of the world.
Sarah Goodie +4 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Children with acute lymphoblastic leukemia (ALL) are at risk of severe outcomes from SARS‐CoV‐2 (SCV2). In the post‐pandemic context, where most children have been infected with SCV2, there are limited data on whether vaccination remains beneficial in children with ALL.
Janna R. Shapiro +11 more
wiley +1 more source
Research Involvement and EngagementHealth research and service delivery often fail to incorporate Indigenous worldviews and local community protocols, as well as historic experiences and knowledge of harmful research practices leaving Indigenous individuals wary of participating in ...
Carolyn M. Melro +8 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background An internal tandem duplication in the gene encoding Fms‐like tyrosine kinase 3 (FLT3‐ITD) is associated with high relapse risk and poor prognosis in acute myeloid leukemia (AML) and plays a crucial role in treatment decisions. Measurable residual disease (MRD) analysis of FLT3‐ITD during and after treatment has shown prognostic ...
Sofie Johansson Alm +11 more
wiley +1 more source
In pursuit of open science, open access is not enough
Science, 2020 Preventing monopolies in knowledge infrastructure is the next battleground for publishers and research institutions After decades of debate on the feasibility of open access (OA) to scientific publications, we may be nearing a tipping point.
Claudio Aspesi, Amy Brand
semanticscholar +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke +4 more
wiley +1 more source